AUTL Autolus Therapeutics

添加自选

4.190
+0.080+1.95%

收盘价 05/03 16:00 (美东)

4.220
+0.030+0.72%

盘后 16:53 (美东)

11.14亿总市值-3491市盈率TTM

关于Autolus Therapeutics公司

Autolus Therapeutics PLC 是一家生物制药公司，致力于开发用于治疗癌症的下一代程序化 T 细胞疗法。公司临床阶段管线包括Obe-cel（obecabtagene autoleucel）、AUTO1/22、AUTO3、AUTO5、AUTO6、AUTO7和AUTO8。

公司介绍

公司代码AUTL

公司名称Autolus Therapeutics

上市日期2018/06/22

发行价格17.00

成立日期2018

CEODr. Christian Itin, PhD.

所属市场纳斯达克

员工数量471

证券类型存托凭证（普通股）

ADS转换比例1.0 : 1.0

年结日12-31

公司地址The Mediaworks,191 Wood Lane,White City

城市伦敦

省份大伦敦

国家英国

邮编W12 7FP

电话44-20-3829-6230

网址http://www.autolus.com

董事高管

姓名
职务
年薪

Dr. Christian Itin, PhD.
Chief Executive Officer and Director
192.11万

Christopher Vann
Senior Vice President and Chief Operating Officer
--

Alexander Swan
Senior Vice President, Chief Human Resources Officer
--

Brent Rice
Senior Vice President and Chief Commercial Officer
--

Dr. Christopher Willia PhD
Senior Vice President and Chief Business Development Officer
--

Robert F. Dolski
Senior Vice President, Chief Financial Officer
--

Martin Pule
Senior Vice President and Chief Scientific Officer
--

David Brochu
Senior Vice President and Chief Technical Officer
--

Dr. Edgar Braendle
Senior Vice President and Chief Development Officer
--

Michael W. Bonney
Chairman of the Board
--

Robert W. Azelby
Director
--

Dr. Ravi Rao, M.D.
Director
--

Dr. Elisabeth Leiderman, M.D.
Director
1.27万

Linda C. Bain
Independent Director
16.95万

William D. Young
Independent Director
17.58万

Dr. Robert Iannone, M.D.
Independent Director
13.49万

Cynthia M. Butitta
Independent Director
16.46万

John E. Berriman
Independent Director
16.31万

Dr. Martin Murphy, PhD
Independent Director
15.83万

Dr. Joseph Anderson, PhD.
Independent Director
19.56万

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度